Filing Details
- Accession Number:
- 0001209191-20-064849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-22 16:42:16
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-22 16:42:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595097 | Corbus Pharmaceuticals Holdings Inc. | CRBP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1451495 | F. Sean Moran | C/O Corbus Pharmaceuticals Holdings, Inc 500 River Ridge Drive Norwood MA 02062 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-18 | 53,610 | $1.00 | 403,220 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-18 | 53,610 | $1.40 | 349,610 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-21 | 87,500 | $1.40 | 437,110 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-21 | 87,500 | $1.75 | 349,610 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-18 | 53,610 | $1.00 | 53,610 | $1.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-21 | 87,500 | $1.40 | 87,500 | $1.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 53,610 | 2024-04-11 | No | 4 | M | Direct | |
| 87,500 | 2026-01-07 | No | 4 | M | Direct |
Footnotes
- The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on December 14, 2020
- The option is currently fully vested.
Billionaire Hedge Funds
